In South Africa’s value-conscious market, HTA determines whether your innovation gets:
✔ Reimbursement approval from medical schemes
✔ Premium pricing recognition
We conduct full-spectrum HTAs that speak the language of:
Funder’s value assessment committees
Hospital procurement decision-makers
SAHPRA’s benefit-risk frameworks
Tailored to Funder's evidence requirements
Simultaneously prove risk sharing initiatives and cost savings
Includes aspects such as length of stay , level of care ,level of acuity ,etc
Where Science Meets Reimbursement Strategy–
Our HTAs go beyond normal day to day practices to actively persuade:
Secure higher premium pricing
We combine SA-specific cost data with global HTA methodologies.
High First-Time Approval Rate
Model Transparency (all assumptions documented)
Step 1: Clinical Pathway Mapping
“Identify all cost touchpoints (LOS, implants, rehab)”
Step 2: Comparator Analysis
Golden standard of care
Step 3: Model Development
“Custom-built for:
In-hospital savings (theatre time, ICU days)
Total episode cost savings
Step 4: Stakeholder Tailoring
“Hospital vs. funder”
Step 5: Negotiation Support
“Live modeling during price talks”
Need to justify your price premium?
Don't Let Funders Undervalue Your Innovation
We emphasize the impact of South African’s , burden of disease
We bridge gaps using:*
Society endorsement
Public Sector utilization
Funder stipulates 12 months waiting period until next submission
12-18 Months post-HTA submission to major schemes.
Need help? Our team is just a message away